Global Bioconjugation Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Bioconjugation market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bioconjugation include WuXi Biologics, Thermo Fisher Scientific, Merck, Roche, Lonza, AbbVie, Sartorius, Promega and Piramal Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bioconjugation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Bioconjugation, also provides the sales of main regions and countries. Of the upcoming market potential for Bioconjugation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioconjugation sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Bioconjugation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Bioconjugation sales, projected growth trends, production technology, application and end-user industry.

Bioconjugation Segment by Company

WuXi Biologics
Thermo Fisher Scientific
Merck
Roche
Lonza
AbbVie
Sartorius
Promega
Piramal Pharma
Genscript Biotech
Danaher
Charles River Laboratories
Catalent
Bio-Rad Laboratories
BD
Agilent
Bioconjugation Segment by Type

Chemical Conjugation
Click Chemistry
Enzyme-mediated Conjugatio
Others
Bioconjugation Segment by Application

Pharmaceutical
Hosptial
Research Institutes
Others
Bioconjugation Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Bioconjugation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioconjugation sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Bioconjugation Market by Type
1.2.1 Global Bioconjugation Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Chemical Conjugation
1.2.3 Click Chemistry
1.2.4 Enzyme-mediated Conjugatio
1.2.5 Others
1.3 Bioconjugation Market by Application
1.3.1 Global Bioconjugation Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Hosptial
1.3.4 Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Bioconjugation Market Dynamics
2.1 Bioconjugation Industry Trends
2.2 Bioconjugation Industry Drivers
2.3 Bioconjugation Industry Opportunities and Challenges
2.4 Bioconjugation Industry Restraints
3 Global Market Growth Prospects
3.1 Global Bioconjugation Revenue Estimates and Forecasts (2020-2031)
3.2 Global Bioconjugation Revenue by Region
3.2.1 Global Bioconjugation Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Bioconjugation Revenue by Region (2020-2025)
3.2.3 Global Bioconjugation Revenue by Region (2026-2031)
3.2.4 Global Bioconjugation Revenue Market Share by Region (2020-2031)
3.3 Global Bioconjugation Sales Estimates and Forecasts 2020-2031
3.4 Global Bioconjugation Sales by Region
3.4.1 Global Bioconjugation Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Bioconjugation Sales by Region (2020-2025)
3.4.3 Global Bioconjugation Sales by Region (2026-2031)
3.4.4 Global Bioconjugation Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Bioconjugation Revenue by Manufacturers
4.1.1 Global Bioconjugation Revenue by Manufacturers (2020-2025)
4.1.2 Global Bioconjugation Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Bioconjugation Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Bioconjugation Sales by Manufacturers
4.2.1 Global Bioconjugation Sales by Manufacturers (2020-2025)
4.2.2 Global Bioconjugation Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Bioconjugation Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Bioconjugation Sales Price by Manufacturers (2020-2025)
4.4 Global Bioconjugation Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Bioconjugation Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Bioconjugation Manufacturers, Product Type & Application
4.7 Global Bioconjugation Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Bioconjugation Market CR5 and HHI
4.8.2 2024 Bioconjugation Tier 1, Tier 2, and Tier 3
5 Bioconjugation Market by Type
5.1 Global Bioconjugation Revenue by Type
5.1.1 Global Bioconjugation Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Bioconjugation Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Bioconjugation Revenue Market Share by Type (2020-2031)
5.2 Global Bioconjugation Sales by Type
5.2.1 Global Bioconjugation Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Bioconjugation Sales by Type (2020-2031) & (Units)
5.2.3 Global Bioconjugation Sales Market Share by Type (2020-2031)
5.3 Global Bioconjugation Price by Type
6 Bioconjugation Market by Application
6.1 Global Bioconjugation Revenue by Application
6.1.1 Global Bioconjugation Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Bioconjugation Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Bioconjugation Revenue Market Share by Application (2020-2031)
6.2 Global Bioconjugation Sales by Application
6.2.1 Global Bioconjugation Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Bioconjugation Sales by Application (2020-2031) & (Units)
6.2.3 Global Bioconjugation Sales Market Share by Application (2020-2031)
6.3 Global Bioconjugation Price by Application
7 Company Profiles
7.1 WuXi Biologics
7.1.1 WuXi Biologics Comapny Information
7.1.2 WuXi Biologics Business Overview
7.1.3 WuXi Biologics Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 WuXi Biologics Bioconjugation Product Portfolio
7.1.5 WuXi Biologics Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Comapny Information
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Merck
7.3.1 Merck Comapny Information
7.3.2 Merck Business Overview
7.3.3 Merck Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Merck Bioconjugation Product Portfolio
7.3.5 Merck Recent Developments
7.4 Roche
7.4.1 Roche Comapny Information
7.4.2 Roche Business Overview
7.4.3 Roche Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Roche Bioconjugation Product Portfolio
7.4.5 Roche Recent Developments
7.5 Lonza
7.5.1 Lonza Comapny Information
7.5.2 Lonza Business Overview
7.5.3 Lonza Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Lonza Bioconjugation Product Portfolio
7.5.5 Lonza Recent Developments
7.6 AbbVie
7.6.1 AbbVie Comapny Information
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 AbbVie Bioconjugation Product Portfolio
7.6.5 AbbVie Recent Developments
7.7 Sartorius
7.7.1 Sartorius Comapny Information
7.7.2 Sartorius Business Overview
7.7.3 Sartorius Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sartorius Bioconjugation Product Portfolio
7.7.5 Sartorius Recent Developments
7.8 Promega
7.8.1 Promega Comapny Information
7.8.2 Promega Business Overview
7.8.3 Promega Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Promega Bioconjugation Product Portfolio
7.8.5 Promega Recent Developments
7.9 Piramal Pharma
7.9.1 Piramal Pharma Comapny Information
7.9.2 Piramal Pharma Business Overview
7.9.3 Piramal Pharma Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Piramal Pharma Bioconjugation Product Portfolio
7.9.5 Piramal Pharma Recent Developments
7.10 Genscript Biotech
7.10.1 Genscript Biotech Comapny Information
7.10.2 Genscript Biotech Business Overview
7.10.3 Genscript Biotech Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Genscript Biotech Bioconjugation Product Portfolio
7.10.5 Genscript Biotech Recent Developments
7.11 Danaher
7.11.1 Danaher Comapny Information
7.11.2 Danaher Business Overview
7.11.3 Danaher Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Danaher Bioconjugation Product Portfolio
7.11.5 Danaher Recent Developments
7.12 Charles River Laboratories
7.12.1 Charles River Laboratories Comapny Information
7.12.2 Charles River Laboratories Business Overview
7.12.3 Charles River Laboratories Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Charles River Laboratories Bioconjugation Product Portfolio
7.12.5 Charles River Laboratories Recent Developments
7.13 Catalent
7.13.1 Catalent Comapny Information
7.13.2 Catalent Business Overview
7.13.3 Catalent Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Catalent Bioconjugation Product Portfolio
7.13.5 Catalent Recent Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Comapny Information
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
7.14.5 Bio-Rad Laboratories Recent Developments
7.15 BD
7.15.1 BD Comapny Information
7.15.2 BD Business Overview
7.15.3 BD Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 BD Bioconjugation Product Portfolio
7.15.5 BD Recent Developments
7.16 Agilent
7.16.1 Agilent Comapny Information
7.16.2 Agilent Business Overview
7.16.3 Agilent Bioconjugation Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Agilent Bioconjugation Product Portfolio
7.16.5 Agilent Recent Developments
8 North America
8.1 North America Bioconjugation Market Size by Type
8.1.1 North America Bioconjugation Revenue by Type (2020-2031)
8.1.2 North America Bioconjugation Sales by Type (2020-2031)
8.1.3 North America Bioconjugation Price by Type (2020-2031)
8.2 North America Bioconjugation Market Size by Application
8.2.1 North America Bioconjugation Revenue by Application (2020-2031)
8.2.2 North America Bioconjugation Sales by Application (2020-2031)
8.2.3 North America Bioconjugation Price by Application (2020-2031)
8.3 North America Bioconjugation Market Size by Country
8.3.1 North America Bioconjugation Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Bioconjugation Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Bioconjugation Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Bioconjugation Market Size by Type
9.1.1 Europe Bioconjugation Revenue by Type (2020-2031)
9.1.2 Europe Bioconjugation Sales by Type (2020-2031)
9.1.3 Europe Bioconjugation Price by Type (2020-2031)
9.2 Europe Bioconjugation Market Size by Application
9.2.1 Europe Bioconjugation Revenue by Application (2020-2031)
9.2.2 Europe Bioconjugation Sales by Application (2020-2031)
9.2.3 Europe Bioconjugation Price by Application (2020-2031)
9.3 Europe Bioconjugation Market Size by Country
9.3.1 Europe Bioconjugation Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Bioconjugation Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Bioconjugation Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Bioconjugation Market Size by Type
10.1.1 China Bioconjugation Revenue by Type (2020-2031)
10.1.2 China Bioconjugation Sales by Type (2020-2031)
10.1.3 China Bioconjugation Price by Type (2020-2031)
10.2 China Bioconjugation Market Size by Application
10.2.1 China Bioconjugation Revenue by Application (2020-2031)
10.2.2 China Bioconjugation Sales by Application (2020-2031)
10.2.3 China Bioconjugation Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Bioconjugation Market Size by Type
11.1.1 Asia Bioconjugation Revenue by Type (2020-2031)
11.1.2 Asia Bioconjugation Sales by Type (2020-2031)
11.1.3 Asia Bioconjugation Price by Type (2020-2031)
11.2 Asia Bioconjugation Market Size by Application
11.2.1 Asia Bioconjugation Revenue by Application (2020-2031)
11.2.2 Asia Bioconjugation Sales by Application (2020-2031)
11.2.3 Asia Bioconjugation Price by Application (2020-2031)
11.3 Asia Bioconjugation Market Size by Country
11.3.1 Asia Bioconjugation Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Bioconjugation Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Bioconjugation Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Bioconjugation Market Size by Type
12.1.1 SAMEA Bioconjugation Revenue by Type (2020-2031)
12.1.2 SAMEA Bioconjugation Sales by Type (2020-2031)
12.1.3 SAMEA Bioconjugation Price by Type (2020-2031)
12.2 SAMEA Bioconjugation Market Size by Application
12.2.1 SAMEA Bioconjugation Revenue by Application (2020-2031)
12.2.2 SAMEA Bioconjugation Sales by Application (2020-2031)
12.2.3 SAMEA Bioconjugation Price by Application (2020-2031)
12.3 SAMEA Bioconjugation Market Size by Country
12.3.1 SAMEA Bioconjugation Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Bioconjugation Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Bioconjugation Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Bioconjugation Value Chain Analysis
13.1.1 Bioconjugation Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Bioconjugation Production Mode & Process
13.2 Bioconjugation Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Bioconjugation Distributors
13.2.3 Bioconjugation Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings